This is the
monthly limit on the various pages on our platform as per your subscription.
See Pricing
1 count = 1 stock search , 1 screener search, 2 stock comparison
If you search same stock multiple times, it would add to the count of total searches done.
This count will be reset on 1st of every month at 12 am IST.
| Limits per month | PRO | PLUS | STARTER | BASIC (FREE) |
| Stock Analytics Searches | UNLIMITED | 500 | 200 | 20 |
| Stock Data Searches | UNLIMITED | 500 | 200 | 20 |
| Stock Comparison Searches | UNLIMITED | 250 | 100 | 10 |
| Stock Screener Searches | UNLIMITED | 20 | 10 | 3 |
| Max Results per Screener | 50 | 20 | 10 | 10 |
| Access to Screeners | ALL | Limited | Minimal | Minimal |
See More Details
BETA DRUGS
Quarterly Results Analysis [Mar2026]
COMMUNITY POLL
for BETA DRUGS |
Please provide your vote to see the results
|
BETA DRUGS Quarterly Results
| Consolidated |
Mar2026 UnAudited |
Dec2025 Audited |
Mar2025 UnAudited |
Dec2024 Audited |
| Revenues |
₹94 Cr |
₹87 Cr |
₹94 Cr |
₹88 Cr |
| Expenses |
₹76 Cr |
₹70 Cr |
₹76 Cr |
₹70 Cr |
| Operating Income |
₹18 Cr |
₹17 Cr |
₹17 Cr |
₹18 Cr |
| Other Income |
₹3 Cr |
₹2 Cr |
₹4 Cr |
₹1 Cr |
| Interest |
₹4 Cr |
₹4 Cr |
₹3 Cr |
₹2 Cr |
| Depreciation |
₹5 Cr |
₹4 Cr |
₹4 Cr |
₹3 Cr |
| Profit Before Tax |
₹12 Cr |
₹10 Cr |
₹12 Cr |
₹12 Cr |
| Profit After Tax |
₹9 Cr |
₹9 Cr |
₹9 Cr |
₹9 Cr |
| EPS |
₹8.93 |
₹8.40 |
₹8.95 |
₹8.86 |
BETA DRUGS Quarterly Revenues
| Quarters |
Revenues |
% Change |
| Mar2026 |
₹94 Cr |
|
7.67 |
| Dec2025 |
₹87 Cr |
|
-6.93 |
| Mar2025 |
₹94 Cr |
|
6.20 |
| Dec2024 |
₹88 Cr |
|
- |
BETA DRUGS Quarterly Operating Profit
|
Operating Profit |
| Q-o-Q |
|
| Y-o-Y |
NA |
| Quarters |
Operating Profit |
% Change |
| Mar2026 |
₹18 Cr |
|
4.08 |
| Dec2025 |
₹17 Cr |
|
-2.07 |
| Mar2025 |
₹17 Cr |
|
-6.00 |
| Dec2024 |
₹18 Cr |
|
- |
|
Operating Margins |
| Q-o-Q |
|
| Y-o-Y |
NA |
| Quarters |
Operating Margin% |
% Change |
| Mar2026 |
18.81% |
|
-3.34 |
| Dec2025 |
19.46% |
|
5.19 |
| Mar2025 |
18.5% |
|
-11.48 |
| Dec2024 |
20.9% |
|
- |
BETA DRUGS Quarterly Profit After Tax
|
Profit After Tax(PAT) |
| Q-o-Q |
|
| Y-o-Y |
NA |
| Quarters |
Profit After Tax |
% Change |
| Mar2026 |
₹9 Cr |
|
6.26 |
| Dec2025 |
₹9 Cr |
|
-5.72 |
| Mar2025 |
₹9 Cr |
|
0.97 |
| Dec2024 |
₹9 Cr |
|
- |
|
PAT Margins |
| Q-o-Q |
|
| Y-o-Y |
NA |
| Quarters |
PAT Margin(%) |
% Change |
| Mar2026 |
9.63 % |
|
-1.33 |
| Dec2025 |
9.76 % |
|
1.35 |
| Mar2025 |
9.63 % |
|
-4.94 |
| Dec2024 |
10.13 % |
|
- |
BETA DRUGS Quarterly Earnings Per Share (EPS)
| Quarters |
EPS |
% Change |
| Mar2026 |
₹8.93 |
|
6.31 |
| Dec2025 |
₹8.4 |
|
-6.15 |
| Mar2025 |
₹8.95 |
|
1.02 |
| Dec2024 |
₹8.86 |
|
- |
You may also like the below Video Courses
Check out Intrinsic Value of Industry Peers of BETA DRUGS